findmyKOL

Andrew Cutler, MD

Enriched profile

SUNY Upstate Medical University

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Lakewood Ranch, FL · Southeast · United StatesSpecialtyPsychiatryFocusAttention Deficit Hyperactivity Disorder+4
Active KOLfindmyKOL type: NationalLatest publication2026Online presenceNone verifiedPayments2021–2025NIH fundingNone on fileWhy? →

Andrew Cutler is an Attention Deficit Hyperactivity Disorder physician affiliated with SUNY Upstate Medical University. OpenAlex indexes 206 publications with 5,132 citations (h-index 37); ClinicalTrials.gov lists 6 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 15 Oct 2026

Andrew Cutler, MD, is affiliated with SUNY Upstate Medical University. The public record shows 206 publications with 5,132 citations (h-index 37), centered on Attention Deficit Hyperactivity Disorder, Schizophrenia research and treatment, Bipolar Disorder and Treatment. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 44 companies.

  • Most recent indexed publication: 2026 · Journal of child and adolescent psychopharmacology
  • Top research focus: Attention Deficit Hyperactivity Disorder
  • 6 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 44 companies

Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Depression (MDD)2 trialsMajor Depressive Disorder2 trialsSchizophrenia1 trialAttention Deficit Disorder with Hyperactivity1 trialPsychotic Disorders1 trialBipolar Disorder

Research focus

OpenAlex concept fingerprint
Attention Deficit Hyperactivity DisorderSchizophrenia research and treatmentBipolar Disorder and TreatmentTreatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Drugs & molecules

across trials, industry payments and publications
Vraylargeneric · CariprazineClinical trials—Industry payments542Publications4Qelbreegeneric · ViloxazineClinical trials—Industry payments264Publications1Fanaptgeneric · IloperidoneClinical trials—Industry payments180Publications2Xelstrymgeneric · DextroamphetamineClinical trials—Industry payments50Publications1EscitalopramClinical trials—Industry payments16Publications1Vyvansegeneric · LisdexamfetamineClinical trials—Industry payments11Publications2AripiprazoleClinical trials—Industry payments2Publications2Lybalvigeneric · Olanzapine / samidorphanClinical trials—Industry payments1342Publications—Aristadageneric · Aripiprazole lauroxilClinical trials—Industry payments949Publications—Caplytageneric · LumateperoneClinical trials—Industry payments578Publications—Auvelitygeneric · Bupropion / dextromethorphanClinical trials—Industry payments411Publications—Rexultigeneric · BrexpiprazoleClinical trials—Industry payments313Publications—

Works with

trial sponsors and companies reporting payments
Tris Pharma, Inc.Clinical trials1Industry payments40Abbvie Inc.Clinical trials—Industry payments586Alkermes, Inc.Clinical trials—Industry payments535Axsome Therapeutics, Inc.Clinical trials—Industry payments432Supernus Pharmaceuticals, Inc.Clinical trials—Industry payments334Teva Pharmaceuticals USA, Inc.Clinical trials—Industry payments331ITI, Inc.Clinical trials—Industry payments306Neurocrine BioSciences, Inc.Clinical trials—Industry payments296Otsuka America Pharmaceutical, Inc.Clinical trials—Industry payments285ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)Clinical trials—Industry payments272Vanda Pharmaceuticals Inc.Clinical trials—Industry payments180E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments162Janssen Pharmaceuticals, IncClinical trials—Industry payments161Corium, LLCClinical trials—Industry payments82Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments58Janssen Global Services, LLCClinical trials—Industry payments41Noven Pharmaceuticals, Inc.Clinical trials—Industry payments39BioXcel Therapeutics, Inc.Clinical trials—Industry payments38Otsuka Pharmaceutical Development & Commercialization, Inc.Clinical trials—Industry payments32H. Lundbeck A SClinical trials—Industry payments31Sage Therapeutics, Inc.Clinical trials—Industry payments27Janssen Scientific Affairs, LLCClinical trials—Industry payments17Otsuka Pharmaceutical Co., Ltd.Clinical trials—Industry payments17Ironshore Pharmaceuticals Inc.Clinical trials—Industry payments14Biogen, Inc.Clinical trials—Industry payments12Takeda Pharmaceuticals U.S.A., Inc.Clinical trials—Industry payments12ACADIA Pharmaceuticals IncClinical trials—Industry payments7LivaNova USA, Inc.Clinical trials—Industry payments6Collegium Pharmaceutical, Inc.Clinical trials—Industry payments5Jazz Pharmaceuticals Inc.Clinical trials—Industry payments5

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
206publications

Distinct works indexed by OpenAlex, matched via ORCID; 10 in PubMed.

5,132citations

Total citations across indexed works.

37h-index

Hirsch index (OpenAlex). i10-index 68.

Clinical & industry

trials, payments and federal funding
6clinical trials

Investigator role on registered studies.

View trials ↓
44companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 15 Oct 2026

Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:

All 6 trial records: search, sort and filter.Explore →

Industry payments

Updated 15 Oct 2026

44 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 115 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 15 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 10 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression
    882 citations2005
    doi.org ↗
  2. 02
    A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial
    392 citations2020
    doi.org ↗
  3. 03
    Sexual dysfunction and antipsychotic treatment
    176 citations2002
    doi.org ↗
  4. 04
    Aripiprazole monotherapy in the treatment of acute bipolar I mania: A randomized, double-blind, placebo- and lithium-controlled study
    171 citations2008
    doi.org ↗
  5. 05
    Cariprazine in Acute Exacerbation of Schizophrenia
    168 citations2015
    doi.org ↗
All 206 cited works: search, sort and filter.Explore →

Network

Updated 15 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Ann Childress37Andrea Marraffino17Gregory W. Mattingly15Charles Yonan14Stephen D’Amico13Scott H. Kollins12Robert L. Findling11João Siffert11Paul Shin11Suresh Durgam10Bev Incledon10Rachelle S. Doody10Norberto J. DeSousa10Craig Chepke9Fred Ledon9Jeffrey H. Newcorn9Nicholas Fry9Richard H. Weisler9Matthew Brams9Andrea E. Formella9Floyd R. Sallee9Amir H Kalali8Huda Shalhoub8Rakesh Jain7Richard D. Zorowitz7David N. Alexander7I. Laszlovszky7Jonathan Rubin7Joseph T. Hull7Timothy E. Wilens6Judith C. Kando6Graeme Donnelly6Marina Komaroff6Kaifeng Lu6William R. Lenderking6Azmi Nasser6Charles Oh6Stanley N. Caroff6Mariacristina Castelli6Christoph U. Correll6

Online presence

Updated 15 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    neiglobal.libsyn.com/e170-a-look-back-at-this-year-in-psychopharmacology-2022-with-dr-andy-cutler

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neiglobal.libsyn.com ↗
  • X / Twitter

    x.com/neiglobal

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.